EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Multidrug resistance and carbapenemase producing Enterobacteriaceae isolated from clinical samples, Addis Ababa, Ethiopia: A cross-sectional study

Yordanos Getachew iD, Tamirat Tamiru, Mekdelawit Fisseha, Sami Sebri iD, Tadesse Shume, Regasa Diriba, Kassu Desta

PLOS One · 13.08.2026 · 21 (8) · e0356234

DOI: 10.1371/journal.pone.0356234 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PLOS One, online erschienen am 13.08.2026. Verfasst von Yordanos Getachew und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology Laboratory, Wudassie Advanced Medical Laboratory, Addis Ababa, Ethiopia. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Bacterial, Carbapenem-Resistant Enterobacteriaceae, beta-Lactamases, Bacterial Proteins. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multidrug-resistant Enterobacteriaceae (MDRE) is among the leading causes of hospital-acquired infections, resulting in prolonged hospitalization, increased healthcare costs, and mortality. Carbapenem are often used as last-resort antibiotics; however, the emergence of carbapenemase-producing Enterobacteriaceae (CPE) has severely limited treatment options. In Ethiopia, data on their burden from routine diagnostic laboratory settings remain limited. This study assessed the prevalence of multidrug-resistant and carbapenemase-producing Enterobacteriaceae among clinical isolates in Addis Ababa.

Methods

A laboratory-based cross-sectional study was conducted from January 2, 2025, to April 2, 2025 on clinical specimens referred to Wudassie Advanced Medical Laboratory in Addis Ababa, Ethiopia. A total of 1105 clinical specimens collected through convenience sampling method were processed. Bacterial identification was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (EXS 3000, Zybio Inc., China). Antimicrobial susceptibility testing was conducted using the Kirby–Bauer disk diffusion method according to Clinical and Laboratory Standards Institute (CLSI 2024) guidelines. Carbapenemase production was confirmed using the modified Carbapenem Inactivation Method (mCIM). Data were analyzed using SPSS version 26.

Results

Of the 1105 clinical specimens, 288/1105 (26.1%) showed bacterial growth. Enterobacteriaceae accounted for 156/288 (54.2%) of the isolates. The most common isolates were Escherichia coli 89/156 (57.1%) and Klebsiella pneumoniae 47/156 (30.1%). Overall, 123/156 (78.8%) of Enterobacteriaceae were multidrug resistant. Carbapenem resistance was detected in 35/154 (22.7%) of isolates, and 30/154 (19.5%) were confirmed as carbapenemase producers. Klebsiella pneumoniae 24/30 (80%) was the predominant carbapenemase-producing organism. Most CPE isolates were recovered from urine specimens, followed by wound and sputum samples.

Conclusion

This study demonstrates a high prevalence of multidrug-resistant and carbapenemase-producing Enterobacteriaceae in Addis Ababa. The findings highlight the urgent need for strengthened antimicrobial stewardship programs, early detection strategies, and enhanced infection prevention and control measures in the private health facilities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, Multiple, BacterialCarbapenem-Resistant Enterobacteriaceaebeta-LactamasesBacterial ProteinsEnterobacteriaceae InfectionsEnterobacteriaceaeEthiopiaHumansCross-Sectional StudiesMicrobial Sensitivity TestsAnti-Bacterial AgentsFemaleMaleCarbapenemsAdultAdolescentChildYoung Adult

Substanzen

carbapenemasebeta-LactamasesBacterial ProteinsAnti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Department of Microbiology Laboratory, Wudassie Advanced Medical Laboratory, Addis Ababa, Ethiopia.
  • Department of Vaccine, Diagnostic, Medical device Research and Development, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
  • Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

ORCID-Profile: Yordanos Getachew, Sami Sebri

Zitieren

APA

Getachew, Y., Tamiru, T., Fisseha, M., Sebri, S., Shume, T., Diriba, R., & Desta, K. (2026). Multidrug resistance and carbapenemase producing Enterobacteriaceae isolated from clinical samples, Addis Ababa, Ethiopia: A cross-sectional study. PLOS One, 21(8), e0356234. https://doi.org/10.1371/journal.pone.0356234

Vancouver

Getachew Y, Tamiru T, Fisseha M, Sebri S, Shume T, Diriba R, et al. Multidrug resistance and carbapenemase producing Enterobacteriaceae isolated from clinical samples, Addis Ababa, Ethiopia: A cross-sectional study. PLOS One. 2026;21(8):e0356234. doi:10.1371/journal.pone.0356234

BibTeX
@article{Getachew2026,
  author = {Getachew, Yordanos and Tamiru, Tamirat and Fisseha, Mekdelawit and Sebri, Sami and Shume, Tadesse and Diriba, Regasa and Desta, Kassu},
  title = {Multidrug resistance and carbapenemase producing Enterobacteriaceae isolated from clinical samples, Addis Ababa, Ethiopia: A cross-sectional study},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {8},
  pages = {e0356234},
  doi = {10.1371/journal.pone.0356234}
}
Kostenlos starten →